Nanopia® TDM Tacrolimus For Immediate Release

October 22, 2015
Sekisui Medical Co., Ltd

"Nanopia® TDM Tacrolimus", a Therapeutic drug monitoring (TDM) reagent, is now available from Sekisui Medical (President: Hideo Tagashira; Head Office: Tokyo, Chuo Ward).

Nanopia® TDM Tacrolimus is a latex turbidimetric immunoassay. This reagent is suitable for use on various types of automated clinical analyzers. The short assay time and ready-to-use liquid state allows the urgent testing in each laboratory.

Sekisui Medical also offers TDM reagents for anti-epileptic drugs, anti-MRSA drugs, immunosuppressive drugs, and antiarrhythmic drug. Sekisui hopes to contribute to new level of convenience by adding Nanopia® TDM Tacrolimus to our TDM reagent product line. In regards to the immunosuppressive drug reagents, Sekisui is the exclusive domestic supplier which offers 3 products (Tacrolimus, Cyclosporine, and Everolimus).

Reference Information

  1. 1Clinical Significance

    Tacrolimus exhibits potent immunosuppressive effect by selectively inhibiting T cell activity. However, tacrolimus has the potential for serious toxicity. Therefore patients under Tacrolimus treatment need to be carefully monitored to prevent the serious side effect such as infections, kidney failure, and damage to nervous system.

  2. 2Product Overview

    Name: Nanopia® TDM Tacrolimus
    Intended use: quantitative determination of tacrolimus in human whole blood
    Assay Principle: latex turbidimetric immunoassay
    Measurement Range: 1.5-30 ng/mL
    Sample Types: Whole Blood (EDTA)

Package Contents - Pricing

Product Name Package Contents Recommended Retail Price
Nanopia® TDM Tacrolimus TACR antibody reagent ① 13mL x 1 ¥137,500
TACR latex reagent ② 8mL x 1
Extraction reagent ③ 15mL x 2

Sold Separately*
Product Name - Package Contents - Pricing

Product Name Package Contents Recommended Retail Price
Tacrolimus Calibrator CAL A: 4mL x 1
CAL B-F:2mL x 1
  • *This product is not intended for in-vitro diagnostic use.
  1. 3Features
    1. 1Ready-to-use liquid reagent
    2. 2Suitable for use on various types of automated clinical analyzers
    3. 3Short assay time supports urgent testing
  2. 4Product Pictures
  • *"Nanopia®" is a registered trademark of Sekisui Medical.